ANGIOTHERAPY
Cancer is reported to have a ected every fourth citizen of a developed country sometime during his or her lifetime. Approximately 400 new incidents emerge per 100,000 people annually (Parkin et al., 2005) . In 2008, it was estimated that there were 12.7 million cancer cases and 7.6 million deaths (within 5 years of diagnosis) globally (Ferley et al., 2010) . Further, this number will continue to increase year by year. But the question remains, what is cancer? ere are many de nitions of cancer and the easiest way to explain it is uncontrollable proliferation of cell. Cancer develops following a number of genetic mutations that cause functional alterations in oncogenes, tumor-suppressor genes and microRNA genes. It can a ect any part of the body by means of uncontrolled and abnormal cell development (Vanhoecke et al., 2005) .
Cancers have been treated in a few ways using conventional methods such as surgery, radiotherapy and chemotherapy (Kintzios & Barberaki, 2004) . Surgery is performed if the cancerous tissues are still localized and have yet to metastasize to other parts of the body. However, this method usually develops scarring a er surgery and may injure healthy tissues and organs adjacent to the cancerous tissues. In addition to that, some remains of neoplastic tissues will be present upon post-surgery (Kintzios & Barberaki, 2004) . Radiation therapy is done by using ionizing wave that are directed to the cancerous cells. e damaging wave causes DNA fragmentation and subsequent apoptotic death of the cancerous cells. However, radiation treatment o en leads to treatment failure due to the presence of radio-resistant cancer cells (Kintzios & Barberaki, 2004; Pesenti et al., 1992) .
Also, chemotherapy is a well-known cancer treatment that uses cytotoxic agents to either damage the DNA of cancerous cells or disrupt the metabolic pathways that are essential for cell survival.
Despite the advancement of medical research and technology, the complete cure for cancer remains elusive. Current cancer therapies, as explained previously, can bring about undesired physical and psychological distress to the patients. erefore, continuing global e orts in the search for novel anticancer compounds that possess high therapeutic e cacy and less adverse reactions compared to the existing anti-cancer drugs in the market are necessary.
An ideal anticancer agent is expected to inhibit, delay or reverse the progression of cancer through its cytotoxicity and/or apoptosis-inducing properties (Naveen Kumar et al., 2012) . e discov- 
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Significance | a brief summary on cancer and its treatment will provide a relaistic insightful knowledge for non-technical persons.
minated by a number of alternative mechanisms, including necrosis. However, when cells die from necrosis, this causes in ammation of the surrounding tissue, which can further distress or cause injury within the body. is critical di erence between apoptosis and necrosis is the reason why apoptosis is the most desirable target mechanism for the induction of cell death in cancer cells and is being widely focused upon in up-to-date cancer-related studies.
Angiogenesis is the process by which new blood vessels form and it is a key factor of the spreading and growing of cancer.
Anti-angiogenesis is being used as a target mechanism for the induction of cell death because of it the cytotoxic and apoptosis-inducing properties. Pytochemicals were a rst antiangiogenic agent to be isolated. In 1990, Ingber et al. reported on the anti-angiogenic properties of Aspergillus fumigates-derived fumagillin. Since Folkman (1971) hypothesized that tumors are angiogenesis dependent, extensive research and development on angiogenesis are being carried out globally. To date, the combination of angiogenesis inhibitors in early chemotherapy treatment has shown a decline in the growth of cancerous cell (Browder et al, 2000) . Secondary metabolites such as aldehydes, alkaloids, avonoids, glycosides, lignans , lipids, nucleic acids, phenols, polysaccharides, proteins and terpenoids have been shown to be capable of stimulating the inhibition of tumor development directly (Kintzios & Barberaki, 2004) . Herbal components and drug compounds can change the rate of activation or detoxi cation of carcinogens by changing the activities of detoxifying metabolic enzymes. Again, the balance between metabolic detoxi cation and activation reactions would depend on the chemical structure of the herbal components or the drug.
